Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Evaluating candidate principal surrogate endpoints.

Peter B Gilbert1, Michael G Hudgens

  • 1Department of Biostatistics, Fred Hutchinson Cancer Research Center, University of Washington, Seattle, Washington 98109, USA. pgilbert@scharp.org

Biometrics
|March 28, 2008
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Comparing Care Coordination and Food Assistance Referrals to Improve Diabetes Outcomes: A Cohort Study.

Journal of general internal medicine·2026
Same author

Combining Observational Studies to Reduce Multiple Biases.

Epidemiology (Cambridge, Mass.)·2026
Same author

MVA.HIVconsvX vaccination-evoked T cell expansion inversely associates with age in people with HIV-1 on antiretroviral therapy.

The Journal of clinical investigation·2026
Same author

A Primer on Large-Sample Statistical Inference for Epidemiologists.

Epidemiologic methods·2026
Same author

Racial Differences in Expected Versus Actual Costs of Cervical Cancer Screening among Low-Income, Underscreened Women in North Carolina.

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology·2026
Same author

Comparative Effectiveness of Levonorgestrel Implant and Depot Medroxyprogesterone Acetate Injectable for Women Living With HIV on Dolutegravir-Based Antiretroviral Therapy.

Pharmacoepidemiology and drug safety·2026
Same journal

Fast penalized generalized estimating equations for large longitudinal functional datasets.

Biometrics·2026
Same journal

Causally-interpretable random-effects meta-analysis.

Biometrics·2026
Same journal

Statistical inference for mean function of partially observed functional time series.

Biometrics·2026
Same journal

Subgroup identification via Interaction Tree and Mixed Model for Repeated Measures with application to Alzheimer's disease.

Biometrics·2026
Same journal

Finite mixtures of linear quantile regressions with concomitant variables: a solution to endogeneity in longitudinal data modeling.

Biometrics·2026
Same journal

Discussion on "INTACT: a method for integration of longitudinal physical activity data from multiple sources" by Jingru Zhang, Erjia Cui, Hongzhe Li, and Haochang Shou.

Biometrics·2026
See all related articles

This study introduces the causal effect predictiveness (CEP) surface to evaluate principal surrogate endpoints. The CEP surface quantifies how well biomarker treatment effects predict clinical endpoint treatment effects, aiding in assessing surrogate value.

Area of Science:

  • Biostatistics
  • Causal Inference
  • Clinical Trials

Background:

  • Principal surrogate endpoints offer a causal framework for evaluating biomarkers.
  • Assessing the predictive accuracy of biomarkers for clinical outcomes is crucial.

Purpose of the Study:

  • Introduce the causal effect predictiveness (CEP) surface as an estimand for principal surrogates.
  • Develop a method to estimate the CEP surface using baseline covariates and case-cohort sampling.

Main Methods:

  • The causal effect predictiveness (CEP) surface is defined to quantify biomarker predictive ability.
  • An estimated likelihood method is developed for CEP surface estimation in randomized clinical trials.
  • Case-cohort sampling is utilized for baseline predictors and biomarkers.

Related Experiment Videos

Main Results:

  • The CEP surface is identifiable with baseline covariates that predict biomarker outcomes.
  • The method allows for estimation of the surrogate value of biomarkers.
  • CEP surface plots can compare the surrogate value of multiple biomarkers.

Conclusions:

  • The proposed method enables robust assessment of principal surrogate endpoints.
  • This approach is valuable for evaluating biomarkers in clinical trials, such as vaccine efficacy.
  • The CEP surface provides a quantitative measure for surrogate endpoint validation.